| Mr Andrew R Brookner, MD | |
|
2015 Grand Concourse, Bronx, NY 10453-4303 | |
| (718) 618-0401 | |
| Not Available |
| Full Name | Mr Andrew R Brookner |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 2015 Grand Concourse, Bronx, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629063888 | NPI | - | NPPES |
| 00871825 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 143694 (New York) | Primary |
| Entity Name | Millie R Fell Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700091055 PECOS PAC ID: 6406746924 Enrollment ID: O20040318000468 |
News Archive
Sigma-Aldrich Corporation announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months.
The orthopaedic joint replacement registry for England, Wales, Northern Ireland and the Isle of Man has launched a new Accountability and Transparency Model for how it monitors implant, hospital and surgeon performance.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
Haitian health authorities on Friday said the death toll from cholera has risen to 6,435 since October and that "the number of people infected with cholera almost reached half a million, although the ministry repeated the epidemic was decreasing," Xinhua reports.
› Verified 7 days ago
| Entity Name | Essen Medical Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366418709 PECOS PAC ID: 1759353501 Enrollment ID: O20040811000885 |
News Archive
Sigma-Aldrich Corporation announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months.
The orthopaedic joint replacement registry for England, Wales, Northern Ireland and the Isle of Man has launched a new Accountability and Transparency Model for how it monitors implant, hospital and surgeon performance.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
Haitian health authorities on Friday said the death toll from cholera has risen to 6,435 since October and that "the number of people infected with cholera almost reached half a million, although the ministry repeated the epidemic was decreasing," Xinhua reports.
› Verified 7 days ago
| Entity Name | Mark Fleckner M.d., P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285850693 PECOS PAC ID: 0446359616 Enrollment ID: O20070628000624 |
News Archive
Sigma-Aldrich Corporation announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months.
The orthopaedic joint replacement registry for England, Wales, Northern Ireland and the Isle of Man has launched a new Accountability and Transparency Model for how it monitors implant, hospital and surgeon performance.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
Haitian health authorities on Friday said the death toll from cholera has risen to 6,435 since October and that "the number of people infected with cholera almost reached half a million, although the ministry repeated the epidemic was decreasing," Xinhua reports.
› Verified 7 days ago
| Entity Name | House Call Medical Services Of New York Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851345946 PECOS PAC ID: 2264517754 Enrollment ID: O20080307000427 |
News Archive
Sigma-Aldrich Corporation announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months.
The orthopaedic joint replacement registry for England, Wales, Northern Ireland and the Isle of Man has launched a new Accountability and Transparency Model for how it monitors implant, hospital and surgeon performance.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
Haitian health authorities on Friday said the death toll from cholera has risen to 6,435 since October and that "the number of people infected with cholera almost reached half a million, although the ministry repeated the epidemic was decreasing," Xinhua reports.
› Verified 7 days ago
| Entity Name | Albany Troy Cataract & Laser Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336389295 PECOS PAC ID: 0941354260 Enrollment ID: O20090820000231 |
News Archive
Sigma-Aldrich Corporation announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months.
The orthopaedic joint replacement registry for England, Wales, Northern Ireland and the Isle of Man has launched a new Accountability and Transparency Model for how it monitors implant, hospital and surgeon performance.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
Haitian health authorities on Friday said the death toll from cholera has risen to 6,435 since October and that "the number of people infected with cholera almost reached half a million, although the ministry repeated the epidemic was decreasing," Xinhua reports.
› Verified 7 days ago
| Entity Name | Bronx Medical Practice Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356726087 PECOS PAC ID: 9739496100 Enrollment ID: O20150917000004 |
News Archive
Sigma-Aldrich Corporation announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months.
The orthopaedic joint replacement registry for England, Wales, Northern Ireland and the Isle of Man has launched a new Accountability and Transparency Model for how it monitors implant, hospital and surgeon performance.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
Haitian health authorities on Friday said the death toll from cholera has risen to 6,435 since October and that "the number of people infected with cholera almost reached half a million, although the ministry repeated the epidemic was decreasing," Xinhua reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Andrew R Brookner, MD 1434 Williamsbridge Rd Fl 2, Bronx, NY 10461-2507 Ph: (718) 618-0401 | Mr Andrew R Brookner, MD 2015 Grand Concourse, Bronx, NY 10453-4303 Ph: (718) 618-0401 |
News Archive
Sigma-Aldrich Corporation announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months.
The orthopaedic joint replacement registry for England, Wales, Northern Ireland and the Isle of Man has launched a new Accountability and Transparency Model for how it monitors implant, hospital and surgeon performance.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
Haitian health authorities on Friday said the death toll from cholera has risen to 6,435 since October and that "the number of people infected with cholera almost reached half a million, although the ministry repeated the epidemic was decreasing," Xinhua reports.
› Verified 7 days ago
Sunju Park, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 3400 Bainbridge Ave, Bronx, NY 10467 Phone: 718-920-2020 | |
Dr. Jonathan Philip Levine, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 111 E 210th St, Dept Of Ophthalmology, Bronx, NY 10467 Phone: 718-920-2020 | |
Dr. Alexander Traykovski, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-518-5300 Fax: 718-239-8395 | |
Dr. Elizabeth Ting Ting Viriya, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 917-748-9167 | |
Dr. Gene Kim, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 3400 Bainbridge Ave, Bronx, NY 10467 Phone: 718-920-4428 | |
Dr. Pearl Rosenbaum, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3333 Henry Hudson Pkwy, Suite 5, Bronx, NY 10463 Phone: 718-548-5800 | |
Dr. Reginald Alivia Camillo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1739 Williamsbridge Rd, Bronx, NY 10461 Phone: 718-824-1560 |